SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 200.79-0.2%Nov 14 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Torben Noerup Nielsen who wrote (14931)2/12/1998 8:30:00 PM
From: Henry Niman  Read Replies (2) of 32384
 
Torben. LGND has about 100 targets (75 in IRs and 25 in STATs) that address almost every pathological condition known. In addition to the receptors and ligands, they are looking at additional regulatory proteins that influence which genes are turned on where and under what conditions. I expect the basic research side to continue moving forward with breathtaking speed.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext